← FDA Drug Approvals (Drugs@FDA)
CARFILZOMIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN PHARMACEUTICALS INC · Approved 2023-01-30
Drug application
- FDA Application #
ANDA209526- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CARFILZOMIB
- Generic name
- Carfilzomib
- Active ingredients
- CARFILZOMIB
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- None (Tentative Approval)
- Sponsor
- MSN PHARMACEUTICALS INC
- First approval
- 2023-01-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown